Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 3686 · SAFE Sunscreen Standards Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 355h Regulation of certain nonprescription drugs that are marketed without an approved drug application

+14 −0Shown
More for 21 U.S.C. § 355h
Read § 355hOnly this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 505G of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355h) is amended by adding at the end the following:(r) Regulations establishing requirements for sunscreen active ingredients.— (1) Evidence and testing standards for sunscreen active ingredients.— The Secretary shall establish, through guidance or regulation, standards for evaluating the safety and efficacy of sunscreen active …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 355h(r)–(r)

Start of § 355h to (r)(2)(A) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(r)(2)(B)(B) Guidance(B) Guidance
Not later than 1 year after November 12, 2025, the Secretary shall issue new draft guidance on how sponsors can use nonclinical testing alternatives to animal testing, as appropriate, to meet safety and efficacy standards under this section for drugs intended for topical administration.Not later than 1 year after November 12, 2025, the Secretary shall issue new draft guidance on how sponsors can use nonclinical testing alternatives to animal testing, as appropriate, to meet safety and efficacy standards under this section for drugs intended for topical administration.
(r)(3)(3) Clarification(3) Clarification
Nothing in this subsection shall be construed to alter, supersede, or limit the standards for making determinations of whether a drug is generally recognized as safe and effective under section 321(p) of this title or the standards set forth under section 355 of this title for determining the safety and effectiveness of drugs.Nothing in this subsection shall be construed to alter, supersede, or limit the standards for making determinations of whether a drug is generally recognized as safe and effective under section 321(p) of this title or the standards set forth under section 355 of this title for determining the safety and effectiveness of drugs.
(r)(r) [inserted: Regulations establishing requirements for sunscreen active ingredients.—]
(r)(1)(1) [inserted: Evidence and testing standards for sunscreen active ingredients.—]
[inserted: The Secretary shall establish, through guidance or regulation, standards for evaluating the safety and efficacy of sunscreen active ingredients, provided that such standards—]
(r)(1)(A)(A) [inserted: ]
[inserted: ensure the safety of consumers based on a comprehensive evaluation of scientific evidence;]
(r)(1)(B)(B) [inserted: ]
[inserted: allow for the use of real-world evidence (as defined in section 505F(b)), observational studies, and other scientifically valid approaches in place of, or to supplement, traditional clinical tests to demonstrate safety and effectiveness; and]
(r)(1)(C)(C) [inserted: ]
[inserted: apply subsection (b)(6)(C) to the regulation of sunscreen active ingredients in demonstrating a prima facie safe nonprescription marketing and use.]
(r)(2)(2) [inserted: Non-animal testing methods for sunscreen active ingredients.—]
(r)(2)(A)(A) [inserted: In general.—]
[inserted: The Secretary shall consider the types of nonclinical tests described in paragraphs (1) through (4) of the first subsection (z) of section 505 (as inserted by section 3209(a)(2) of the Health Extenders, Improving Access to Medicare, Medicaid, and CHIP, and Strengthening Public Health Act of 2022 (division FF of Public Law 117–328)), or any other alternative to animal testing that the Secretary deems appropriate, in the consideration of sunscreen active ingredients.]
(r)(2)(B)(B) [inserted: Guidance.—]
[inserted: Not later than 180 days after the date of enactment of this subsection, the Secretary shall issue new guidance on how sponsors can use nonclinical testing alternatives to animal testing to meet safety and efficacy standards for sunscreen active ingredients.]

Step through the changes